V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10008863 | 10004609 | 1.67 | 70.3 | null | 2016-09-17 | 2016-10-01 | CARBOPLATIN | N | N | 10461240 | LENALIDOMIDE |
| 10008864 | 10004613 | 1.61 | 66 | null | 2019-01-30 | 2019-02-02 | LENALIDOMIDE | 02 | N | 10461654 | LENALIDOMIDE |
| 10008865 | 10004617 | 1.6 | 55.2 | Palliative (P) | 2019-06-07 | 2019-09-22 | Azacitidine | Y | N | 10461710 | AZACITIDINE |
| 10008866 | 10004624 | 1.83 | null | Palliative (P) | 2017-07-28 | 2017-12-15 | Carboplatin + Pemetrexed | N | N | 10462879 | BEVACIZUMAB |
| 10008867 | 10004649 | 1.74 | 80.6 | Palliative (P) | 2014-09-11 | 2014-11-10 | Capecitabine | 02 | N | 10465732 | CAPECITABINE |
| 10008868 | 10004653 | 1.73 | 83 | null | 2019-06-16 | 2019-06-16 | Capecitabine | N | N | 10466150 | CAPECITABINE |
| 10008869 | 10004657 | 1.71 | 75.8 | Palliative (P) | 2018-10-27 | 2018-10-27 | BCG Intravesical | N | N | 10466478 | CARBOPLATIN + VINORELBINE |
| 10008870 | 10007371 | 1.6 | null | Palliative (P) | 2018-07-13 | 2018-07-14 | null | 02 | null | 10466668 | CARBOPLATIN |
| 10008871 | 10004662 | 1.8 | null | Palliative (P) | 2014-06-24 | 2014-08-30 | Pemetrexed | 02 | N | 10467268 | NOT MATCHED |
| 10008872 | 10004669 | 1.78 | 83.8 | Palliative (P) | 2017-09-13 | 2017-09-13 | Pemetrexed | Y | N | 10467497 | GEMCARBO |
| 10008873 | 10004671 | 1.73 | 72.7 | Palliative (P) | 2015-03-04 | 2015-04-15 | Abiraterone | N | N | 10467585 | LENALIDOMIDE |
| 10008874 | 10004684 | 1.63 | null | Palliative (P) | 2019-01-21 | 2019-01-21 | Carboplatin AUC 2 - 5 | N | N | 10468787 | ABIRATERONE |
| 10008875 | 10004691 | 1.64 | 67 | Palliative (P) | 2017-11-22 | 2017-12-17 | Azacitidine | N | null | 10469418 | AZACITIDINE |
| 10008876 | 10004692 | 1.74 | 94.6 | Palliative (P) | 2017-07-03 | 2017-07-11 | CARBOPLATIN | N | N | 10469501 | IBRUTINIB |
| 10008877 | 10004695 | 1.61 | 74.2 | Curative (C) | 2019-02-22 | 2019-02-25 | Carboplatin + Vinorelbine Oral | 2 | N | 10470305 | PEMETREXED |
| 10008878 | 10004699 | 1.74 | 72 | Adjuvant (A) | 2018-09-10 | 2018-09-10 | Carboplatin + Pemetrexed | 2 | N | 10470857 | CARBOPLATIN |
| 10008879 | 10004704 | 0 | 85.2 | Curative (C) | 2016-10-13 | 2016-10-13 | CARBOPLATIN + VINORELBINE | N | N | 10471856 | CARBOPLATIN + PEMETREXED |
| 10008880 | 10004709 | null | 77.3 | Palliative (P) | 2018-12-27 | 2018-12-31 | Fluorouracil 96hr infusion+R(4g/m2) | N | N | 10472325 | IBRUTINIB |
| 10008881 | 10004712 | 1.74 | 76 | Palliative (P) | 2016-02-09 | 2017-06-10 | Trial Unspecified | N | N | 10472618 | TRIAL |
| 10008882 | 10007390 | 1.65 | 72.3 | Not known (9) | 2019-01-24 | 2019-01-24 | Capecitabine | null | null | 10473072 | CAPECITABINE |
| 10008883 | 10004724 | null | 69.6 | Palliative (P) | 2015-04-03 | 2015-10-11 | GemCarbo Days 1+8 | N | N | 10476222 | CARBOPLATIN + VINORELBINE |
| 10008884 | 10007394 | 1.8 | 71 | Adjuvant (A) | 2017-10-06 | 2017-11-24 | CARBOPLATIN + PACLITAXEL | 02 | N | 10476241 | CARBOPLATIN + PACLITAXEL |
| 10008885 | 10004727 | null | 65.8 | Adjuvant (A) | 2017-06-06 | 2017-06-22 | Temozolomide 150mg/m2 | 1 | N | 10477547 | TEMOZOLOMIDE |
| 10008886 | 10004738 | 1.49 | 59.95 | Neo-adjuvant (N) | 2014-08-24 | 2015-06-18 | IBRUTINIB | 2 | N | 10479804 | IBRUTINIB |
| 10008887 | 10004743 | 1.67 | 65 | Palliative (P) | 2017-08-24 | 2017-08-24 | Carboplatin AUC 2 - 5 | 02 | N | 10480034 | BCG |
| 10008888 | 10004750 | 1.49 | 76.7 | Neo-adjuvant (N) | 2018-01-24 | 2018-01-24 | Carboplatin + Pemetrexed | N | N | 10480320 | CARBOPLATIN |
| 10008889 | 10004769 | 1.6 | 56.1 | Palliative (P) | 2017-12-20 | 2018-01-03 | IBRUTINIB | 02 | N | 10481342 | CVP R |
| 10008890 | 10007411 | 1.59 | 70 | Palliative (P) | 2018-10-26 | 2018-10-26 | GEMCARBO | 02 | N | 10481483 | CARBOPLATIN + VINORELBINE |
| 10008891 | 10004776 | 1.78 | null | Palliative (P) | 2016-03-24 | 2016-07-14 | Carboplatin + Pemetrexed | 2 | N | 10481596 | CTD |
| 10008892 | 10004783 | 1.81 | 92.3 | Curative (C) | 2016-09-02 | 2016-12-03 | Pemetrexed | null | null | 10482327 | LENALIDOMIDE |
| 10008893 | 10004795 | 1.75 | 62.9 | Palliative (P) | 2014-08-07 | 2015-01-23 | CISPLATIN + VINORELBINE | 99 | N | 10483677 | TAC |
| 10008894 | 10004798 | 1.57 | 48 | null | 2018-12-04 | 2018-12-26 | Carboplatin + Liposomal Doxorubicin | 02 | N | 10484074 | NINTEDANIB |
| 10008895 | 10004799 | 1.83 | 0 | Palliative (P) | 2017-09-21 | 2017-09-21 | Obinutuzumab | 2 | N | 10484131 | CISPLATIN + GEMCITABINE |
| 10008896 | 10004800 | 1.7 | 84.6 | Palliative (P) | 2018-04-24 | 2018-07-03 | PIXANTRONE | 02 | N | 10484169 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 10008897 | 10007429 | 1.72 | 97.7 | Palliative (P) | 2018-02-05 | 2018-02-16 | PLATFORM Trial + MEDI4736 | N | N | 10484984 | CAP + RT |
| 10008898 | 10004815 | 1.78 | 110 | Palliative (P) | 2017-12-04 | 2017-12-16 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | 10485023 | VINORELBINE |
| 10008899 | 10004822 | 1.57 | 52.6 | Curative (C) | 2018-07-28 | 2018-09-21 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | N | N | 10485667 | PERTUZUMAB + TRASTUZUMAB |
| 10008900 | 10004830 | 1.52 | null | Neo-adjuvant (N) | 2018-02-01 | 2018-02-01 | DA 3 + 10 | N | N | 10486160 | ECX |
| 10008901 | 10004833 | null | 100 | Palliative (P) | null | 2018-08-01 | VISMODEGIB | N | N | 10486417 | CISPLATIN + PEMETREXED |
| 10008902 | 10007441 | 1.78 | 78 | Palliative (P) | 2016-11-12 | 2016-12-30 | FLUOROURACIL + MITOMYCIN + RT | 2 | N | 10487421 | CLADRIBINE |
| 10008903 | 10004852 | 1.82 | 70.35 | Palliative (P) | 2018-08-10 | 2018-09-29 | ECX | 02 | N | 10487753 | BUSULPHAN |
| 10008904 | 10004855 | 1.8 | 85.4 | Palliative (P) | 2016-08-11 | 2016-08-11 | Everolimus 10mg | 1 | N | 10487949 | EOX |
| 10008905 | 10004858 | 1.71 | 94.9 | Palliative (P) | 2018-12-02 | 2018-12-05 | Enzalutamide | 2 | Y | 10487958 | CYCLOPHOSPHAMIDE + ETOPOSIDE |
| 10008906 | 10004862 | 1.77 | 90.3 | Palliative (P) | null | 2018-08-27 | CHLORAMBUCIL + ETOPOSIDE + LOMUSTINE | 02 | N | 10488669 | CETUXIMAB |
| 10008907 | 10004864 | 1.57 | 71.3 | Curative (C) | 2018-04-11 | 2018-09-13 | Bevacizumab+Carbo+Pacliaxel | 2 | N | 10488696 | CRIZOTINIB |
| 10008908 | 10004875 | 1.74 | 74.4 | Neo-adjuvant (N) | 2016-01-24 | 2016-02-20 | Methotrexate intrathecal | 2 | N | 10489253 | ABVD |
| 10008909 | 10004881 | null | null | Palliative (P) | 2017-09-03 | 2017-09-16 | Bortezomib + Panobinostat | N | N | 10489526 | CARBOPLATIN + LIPOSOMAL DOX |
| 10008910 | 10007471 | 1.73 | 105 | Palliative (P) | 2017-08-10 | 2017-09-29 | ECX | 2 | N | 10493601 | CISPLATIN + GEMCITABINE |
| 10008911 | 10004911 | 1.76 | 77.9 | Curative (C) | 2018-06-15 | 2018-06-17 | REMODLB TRIAL | N | null | 10494098 | CYCLOPHOSPHAMIDE + ETOPOSIDE |
| 10008912 | 10004916 | 1.7 | 74.7 | Not known (9) | 2014-09-25 | 2014-12-13 | Temozolomide + RT | N | null | 10494795 | REMODL TRIAL |